You are here

Eyelea

Regeneron Pharmaceuticals Inc: Eylea and Praluent Sales Growth Under Risk

Bidness, ETC

Sat, 06/18/16 - 02:21 pm

Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers

Fierce Pharma Marketing

Thu, 11/6/14 - 09:03 am

Gilead Sciences

Vertex Pharmaceuticals

Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia

Yahoo

Wed, 02/20/13 - 05:12 pm

diabetic macular edema

3 Drugs Approved, but Only 1 Matters

Motley Fool

Tue, 08/7/12 - 11:43 am

Regeneron settles with Genentech over eye drug

Yahoo/AP

Tue, 01/3/12 - 11:29 am

Regeneron Pharma and Bayer begin late-stage trial of eye drug Eylea in China

Yahoo/AP

Mon, 11/28/11 - 11:41 am

retinal disease

This Biotech Has Almost Everything Going for It

Motley Fool

Mon, 11/21/11 - 06:28 pm

Regeneron up 10% on FDA approval

Marketwatch

Mon, 11/21/11 - 12:59 pm

Regeneron: A Poke in the Eye From the FDA

Motley Fool

Fri, 08/19/11 - 09:05 am

macular degeneration

Biotech Calendar: Key Dates for August

TheStreet.com

Tue, 08/2/11 - 12:29 pm

Gilead Sciences

Seattle Genetics